FTFrank Träisk

Frank Träisk

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Frank Träisk has a total of 22 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Optic nerve involvement in Lyme disease

    by Frank Träisk, Lars Lindquist

    The tick-borne spirochete Borrelia burgdorferi sensu lato can cause several neural manifestations from the peripheral and central neural system. There are several case reports in the literature of optic nerve involvement in association with Lyme neuroborreliosis, but clinical guidelines as to when Lyme disease should be considered in optic neuropathy is lacking. Papilledema caused by raised intracranial pressure in Lyme meningitis seems mainly to affect children, although some adult cases have been reported. Very few cases of retrobulbar optic neuritis, papillitis, neuroretinitis and ischemic optic neuropathy have shown evidence of a strong association with Lyme neuroborreliosis. Optic neuropathy in Lyme neuroborreliosis is rare. The cases reported in the literature are not sufficient for making a list of clinical 'red flags'. However, in adult cases, special attention seems reasonable in patients with painless visual loss, bilateral optic nerve head swelling with or without an elevated cerebrospinal fluid opening pressure. In endemic areas, any optic neuropathy may still be considered for a Lyme neuroborreliosis work-up. The use of accepted criteria for establishing the diagnosis of Lyme neuroborreliosis is emphasised.


  • Open Access

    Thyroid-Associated Ophthalmopathy after Treatment for Graves’ Hyperthyroidism with Antithyroid Drugs or Iodine-131

    by Frank Träisk, Leif Tallstedt, Mirna Abraham-Nordling, Tommy Andersson, Gertrud Berg, Jan Calissendorff, Bengt Hallengren, Pavo Hedner, Mikael Lantz, Ernst Nyström, et al.

    Context: Previous randomized trials have suggested an association between radioiodine treatment for Graves’ hyperthyroidism and thyroid-associated ophthalmopathy (TAO). Objectives: The aim of the study was to compare the occurrence of worsening or development of TAO in patients who were treated with radioiodine or antithyroid drugs. Design: We conducted a randomized trial (TT 96) with a follow-up of 4 yr. Patients, Setting, and Intervention: Patients with a recent diagnosis of Graves’ hyperthyroidism were randomized to treatment with iodine-131 (163 patients) or 18 months of medical treatment (150 patients). Early substitution with T4 was given in both groups. Main Outcome Measure: Worsening or development of TAO was significantly more common in the iodine-131 treatment group (63 patients; 38.7%) compared with the medical treatment group (32 patients; 21.3%) (P < 0.001). Results: The risk for de novo development of TAO was greater in patients treated with iodine-131 (53 patients) than with medical treatment (23 patients). However, worsening of TAO in the 41 patients who had ophthalmopathy already before the start of treatment was not more common in the radioiodine group (10 patients) than in the medical group (nine patients). Smoking was shown to influence the risk of worsening or development of TAO, and smokers treated with radioiodine had the overall highest risk for TAO. However, in the group of smokers, worsening or development of TAO was not significantly associated with the choice of treatment for hyperthyroidism. Conclusions: Radioiodine treatment is a significant risk factor for development of TAO in Graves’ hyperthyroidism. Smokers run the highest risk for worsening or development of TAO irrespective of treatment modality. Radioiodine treatment for Graves’ hyperthyroidism (when compared to anti-thyroid drug treatment),and smoking increase the risk for the development of thyroid associated ophthalmopathy.


  • Saccadic Eye Movement Velocity Measured with the Infrared Reflection and Search Coil Eye-Tracking Systems in Patients with Thyroid-Associated Ophthalmopathy

    by F. Träisk, R. Bolzani, L. Tallstedt, H. D. Schworm, J. Ygge

    Background Assessment of changes in saccade velocity may be useful in the early detection of thyroid-associated ophthalmopathy (TAO). Two eye-tracking systems were used to measure the velocity of saccadic eye movements in patients with TAO. Method Fourteen patients with active TAO and 14 healthy controls were enrolled for recordings with two eye-tracking systems: the magnetic scleral search coil (MSC; Skalar Medical) and the infrared reflection systems (IR; Orbit XY-1000). The MSC is generally considered the “gold standard” method for tracking of rapid eye movements. The IR system uses novel computer technology and is based on sampling of reflected infrared light from the surface of the eyes. Main sequence plots constructed from the recorded saccadic peak velocity and amplitude were analyzed for differences between patients and healthy controls. Results There were no significant differences between patients with TAO and healthy controls in the constructed main sequence plots of maximum velocity (VMAX) and the slope constant (C). Conclusions Main sequence analysis of saccadic eye movements was not useful for detecting TAO in this experimental setting with either of the two eye-tracking methods. This is hypothesized to be due to compensation for the early orbital changes in TAO by neural adaptation of the saccades in the brain stem. The contradictory results between this and previous studies cannot be easily explained. We assume that there is a large heterogeneity in the saccadic eye movement performance in both the normal population and the TAO-population. Also, differences in the study design may cause dissimilar outcomes and hence incoherent conclusions. A non-invasive recording system that is able to generate a minimum amount of intra- and inter-individual variability and a study design where normal variability can be reduced to a minimum may be useful for future identification of early eye muscle changes in TAO.


  • A comparison between the magnetic scleral search coil and infrared reflection methods for saccadic eye movement analysis

    by F. Träisk, R. Bolzani, J. Ygge

    A non-invasive eye tracking system, based on pulsed infrared light (IR), was compared with the magnetic scleral search coil method (MSC) for saccadic eye movement recordings. Ten normal subjects performed horizontal and vertical saccades recorded with both methods. Eight recordings were complete and analysed for maximum peak velocity (V MAX) and constant (C) of the main sequence curve. The IR recordings showed significantly higher peak velocity values than the MSC system and generally more inter-individual variability. No significant difference regarding peak velocity was detected between abducting and adducting saccades or between upward and downward saccades with either of the systems. Horizontal saccades had higher peak velocities with both techniques. Comparison of the main sequence plots of the IR and MSC eye tracking techniques reveals that the IR system yields higher values of maximum peak velocity and the constant, the differences being similar for eye movements in different directions. There are various possible explanations for the lower maximum velocity of the MSC recordings, e.g. slipping of the coil annulus on the surface of the eye and a change of the oculomotor command signal induced by wearing the coil. Also, artefacts associated with the IR recording system may cause overestimations of the saccadic velocity and, furthermore, contribute to the higher variability of the IR recordings.


  • Open Access

    Thyroid associated ophthalmopathy: botulinum toxin A in the treatment of upper eyelid retraction – a pilot study

    by Frank Träisk, Leif Tallstedt

    : Purpose: Eyelid retraction in patients with thyroid associated ophthalmopathy is a common cause of eye discomfort and a disfigured facial appearance. The aim of this pilot study was to evaluate the effects and safety of inducing a temporary partial ptosis of the eyelid through injection of botulinum toxin A into the levator palpebrae superioris muscle.Methods: Nine patients were treated. They were followed up with ophthalmologic examinations and self‐assessment questionnaires until the point at which they either required renewed treatment or had no residual effect of the first injection. Maximum follow‐up time was twenty weeks.Results: In all eyes but one there was a lowering of the eyelid position one week after treatment and all these patients reported an improvement of eye appearance and symptoms. There was variability in the degree of lowering of the eyelid with the same dose of injected botulinum toxin A. It was also difficult to predict the time interval needed for re‐treatment. Ptosis impairing visual acuity was not a consequence of the treatment in any of the patients. One week after treatment two patients experienced increased diplopia but only one showed transient change in Lees screen measurement of eye motility.Conclusion: Botulinum toxin A injection may be used to lower the upper eyelid position in patients awaiting eyelid surgery. The treatment safely relieved symptoms and improved eye appearance. However, treatment was short term and difficult to predict. There is also an inherent risk of transient diplopia.